Aeon Global Health (AGHC) Stock Price, News & Analysis

Company Overview

AEON GLOBAL HEALTH (OTCMKTS:AGHC) is a diversified healthcare company focused on the development and commercialization of innovative diagnostic and therapeutic solutions. The company’s primary activities span the research, development and marketing of point-of-care diagnostic devices, advanced pharmaceutical formulations and biotechnology-based treatments. By integrating life sciences research with precision diagnostics, AEON GLOBAL HEALTH aims to advance early disease detection and improve patient outcomes across a range of chronic and infectious conditions.

The company’s product portfolio includes portable diagnostic instruments designed to deliver rapid, laboratory-grade results at the point of need. These devices leverage proprietary sensor technologies and cloud-enabled analytics to support the management of diabetes, cardiovascular disease and renal impairment. In addition to its hardware platforms, AEON GLOBAL HEALTH develops companion reagents, assay kits and data-driven software solutions that assist healthcare providers in treatment planning and monitoring.

With headquarters in Miami, Florida, AEON GLOBAL HEALTH maintains research and manufacturing facilities in North America, Europe and Asia. The company’s global footprint enables it to serve hospitals, clinical laboratories, diagnostic centers and government health agencies in emerging and developed markets. Strategic partnerships in China and India support local regulatory approval and distribution, while collaborative research agreements with academic institutions help drive next-generation diagnostic innovations.

Founded in 2018 as a Delaware corporation, AEON GLOBAL HEALTH has grown through internal R&D and targeted acquisitions of niche life science firms. The leadership team is headed by Chief Executive Officer Dr. Frank E. Davis, a veteran of the biotechnology industry with more than 25 years of experience in diagnostics development. Chief Financial Officer Michael L. Hanley oversees financial planning and investor relations, while Chief Medical Officer Dr. Susan M. Lee directs clinical strategy and regulatory affairs. Under this management group, AEON GLOBAL HEALTH continues to advance its mission of delivering cutting-edge health solutions that address unmet medical needs worldwide.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AGHC Stock Analysis - Frequently Asked Questions

How do I buy shares of Aeon Global Health?

Shares of AGHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aeon Global Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeon Global Health investors own include TD Ameritrade (AMTD), Basf (BAS), Conduent (CNDT), Canadian Natural Resources (CNQ), CVR Refining (CVRR), Concho Resources (CXO) and Consolidated Edison (ED).

Company Calendar

• Today: 7/16/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:AGHC
• CIK: 885074
• Web: www.authentidate.com
• Phone: (888) 661-0225
• Fax: 908-673-9920
• Employees: 52
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A